| PSMD3 |
PSMD3: 26S proteasome non-ATPase regulatory subunit 3 |
WDR71 |
WDR71, PAAF1: Proteasomal ATPase-associated factor 1 |
0.495 |
Evidence |
O
|
| COPB2 |
COPB2: Coatomer subunit beta' |
PCYT1A |
IPI00384629 |
0.492 |
Evidence |
O
|
| PHGDH |
PHGDH, PGDH3: D-3-phosphoglycerate dehydrogenase |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
0.492 |
Evidence |
|
| PHGDH |
PHGDH, PGDH3: D-3-phosphoglycerate dehydrogenase |
ADH5 |
IPI00218446 |
0.492 |
Evidence |
|
| CHEK1 |
CHEK1, CHK1: Serine/threonine-protein kinase Chk1 |
PHGDH |
PHGDH, PGDH3: D-3-phosphoglycerate dehydrogenase |
0.492 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
FAT4 |
FATJ, FAT4: FAT tumor suppressor homolog 4 |
0.492 |
Evidence |
|
| BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
0.492 |
Evidence |
|
| CRYAA |
CRYAA, CRYA1, HSPB4: Alpha-crystallin A chain |
CRYBA2 |
CRYBA2: Beta-crystallin A2 |
0.492 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
DARC |
DARC, FY, GPD: Duffy antigen/chemokine receptor |
0.492 |
Evidence |
|
| RPS13 |
RPS13: 40S ribosomal protein S13 |
EIF4G2 |
EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 |
0.492 |
Evidence |
|
| SUMO2 |
SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor |
TKT |
TKT: Transketolase |
0.492 |
Evidence |
|
| SUMO2 |
SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor |
EEF1A1 |
EEF1A1: Elongation factor 1-alpha |
0.492 |
Evidence |
|
| COPB2 |
COPB2: Coatomer subunit beta' |
SUMO2 |
SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor |
0.492 |
Evidence |
|
| CTPS |
CTPS: CTP synthase 1 |
SUMO2 |
SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor |
0.492 |
Evidence |
|
| EEF2 |
EEF2, EF2: Elongation factor 2 |
SUMO2 |
SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor |
0.492 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
SUMO2 |
SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor |
0.492 |
Evidence |
|
| TOP1 |
TOP1: DNA topoisomerase 1 |
SUMO2 |
SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor |
0.492 |
Evidence |
|
| SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
GUCA1C |
GUCA1C, GCAP3: Guanylyl cyclase-activating protein 3 |
0.492 |
Evidence |
|
| DIP13B |
APPL2, DIP13B: DCC-interacting protein 13-beta |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
0.492 |
Evidence |
|
| GAB1 |
GAB1: GRB2-associated-binding protein 1 |
DUSP10 |
DUSP10, MKP5: Dual specificity protein phosphatase 10 |
0.492 |
Evidence |
|
| BIRC1 |
BIRC1, NAIP: Baculoviral IAP repeat-containing protein 1 |
BIRC7 |
BIRC7, KIAP, UNQ5800/PRO19607/PRO21344, LIVIN, MLIAP, RNF50: Baculoviral IAP rep |
0.492 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
GUCA1C |
GUCA1C, GCAP3: Guanylyl cyclase-activating protein 3 |
0.492 |
Evidence |
|
| DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
ARHGEF1 |
ARHGEF1: Rho guanine nucleotide exchange factor 1 |
0.492 |
Evidence |
|
| CDK8 |
CDK8: Cell division protein kinase 8 |
MINK1 |
MAP4K6, MINK1, MINK: Misshapen-like kinase 1 |
0.492 |
Evidence |
|
| MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
RHEB |
RHEB, RHEB2: GTP-binding protein Rheb precursor |
0.492 |
Evidence |
|